THERAPIES - SOMMAIRE JUILLET AOUT 2023

Le Vol 78 - N°4 - JUILLET AOUT 2023 est en ligne

Au sommaire

• Editorials

  • ·Hydroxychloroquine and COVID-19: The endgame!

    Dominique Deplanque

  • ·Evidence-based medicine: Friend and foe

    Christian Funck-Brentano

  • ·Propofol and infectious complications

    Joelle Micallef, Tessa Pietri

• Clinical research

  • ·Project rebuild the evidence base (REB): A method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patient
  • Rémy Boussageon, Clara Blanchard, Elodie Charuel, Thibault Menini, Bruno Pereira, Florian Naudet, Behrouz Kassai, François Gueyffier, Michel Cucherat, Hélène Vaillant-Roussel

• Pharmacokinetics

  • ·Effects of missed dose and delayed dose quetiapine on its pharmacokinetics and pharmacodynamics

    Janthima Methaneethorn

• Pharmacovigilance

  • ·Complications infectieuses liées à l’utilisation du propofol : une nouvelle série de cas et revue de la littérature

    Badreddine Moukafih, Soufiane El Marrakchi, Ismail Bennani, Mounia Lakhdar-Idrissi, Moustapha Hida, Abdeslam El Kartouti, Sanae Achour

  • ·Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation

    Long Mei, Sa Li, Qianqian Fan, Bin Zhao, Dan Mei, Roxane Took, Jiancun Zhen

  • ·Drug-related risk of hospital readmission in children with chronic diseases, a systematic review

    Elham Jaberi, Behrouz Kassai, Anick Berard, Guillaume Grenet, Kim An Nguyen

  • ·Adverse effect of Pneumocystis Jirovecii infection associated with rituximab therapy for autoimmune disease are more frequently reported in older vs. younger patient

    Léa Lemoine, Marie Sara Agier, Alexandra Audemard-Verger, Laurent Chouchana, Joëlle Michot, Annie Pierre Jonville-Béra, Francois Maillot

  • ·Safety profile of the lopinavir/ritonavir combination before and during the SARS-CoV-2 pandemic

    Pauline Lory, Sandrine Combret, Joelle Michot, Gwenaelle Veyrac, Laurent Chouchana, Aurélie Grandvuillemin

• Clinical research

  • ·OLGA, plateforme numérique d’aide au pilotage de réseaux nationaux de recherche en santé : un modèle pour les organisations complexes ?

    Vincent Diebolt, Christine Trillou, Johanna Steen, Mélanie Rigodanzo, Allan Wilsdorf, Sarhan Yaïche

• Letters to Editor

  • ·Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted

    Damien Barraud, Lonni Besançon, Elisabeth M. Bik, Eric Billy, Franck Clarot, Fabrice Frank, Anthony Guihur, David Hajage, Karine Lacombe, Hervé Maisonneuve, Mathieu Molimard, Matthieu Mulot, Alexander Samuel

  • ·Letrozole induced visual hallucination

    Ahmed Zaiem, Khouloud Ferchichi, Ghozlane Lakhoua, Widd Kaabi, Sana Rebii Debbiche, Imen Aouinti, Ons Charfi, Sihem El Aidli

  • ·An atypical Ramsey Hunt syndrome after covid 19 immunization

    Ghozlane Lakhoua, Ons Charfi, Sana Dabbeche, Ahmed Zaiem, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli

  • ·Les contraceptifs hormonaux en interaction avec les thymorégulateurs antiépileptiques et le lithium : quelles implications thérapeutiques ?

    Youssef Ouazzani Housni Touhami, Yassine Benhaddouch, Zakaria Hammani, Amine Bout, Chadya Aarab, Rachid Aalouane

  • ·De novo psoriasis induced by ChAdOx1-S COVID 19 vaccine

    Ahmed Zaiem, Mouna Daldoul, Talel Badri, Ghozlane Lakhoua, Widd Kaabi, Sana Rebii Debbiche, Sarrah Kastalli, Imen Aouinti, Ons Charfi, Sihem El Aidli

  • ·About two cases of possible topical steroid withdrawal reaction

    Johana Béné, Flore Durieux, Sandrine Bergeron, Camille Potey, Bénédicte Lebrun-Vignes, Delphine Staumont-Sallé, Sophie Gautier

  • ·Atypical neurological toxicity attributed to oxaliplatin

    Wiem Daly, Ghozlane Lakhoua, Ahmed Zaiem, Ons Charfi, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli

  • ·Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine

    Taieb Ach, Fatma Kammoun, Hamza El Fekih, Nassim Ben Haj Slama, Siwar Kahloun, Fatma Ben Fredj, Chédia Laouani, Koussay Ach

  • ·Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence

    Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

  • ·The need to shed light on potential insidious SARS-CoV-2 post-vaccination pituitary lesions

    Taieb Ach, Mounira El Euch

  • ·Benralizumab-induced interstitial granulomatous dermatitis: A case report

    Farid Mankouri, Laurie Gosse, Tom Handwerk, Benjamin Guyot, Laurie Pahus, Pascal Chanez, Safia Abed, Thierry Boye, Jean-Jacques Morand, Aude Valois

  • ·Severe hepatitis after sevoflurane anesthesia in an 8-month old child with a Down syndrome: Case report and review of the literature

    Lucas Aghnatios, Clément Karsenty, Caroline Viard, Claire de Canecaude, Geneviève Durrieu

  • ·La crise climatique, un argument de poids pour améliorer la déclaration des liens d’intérêt

    Nicolas Faure

  • ·Only blame SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out

    Josef Finsterer, Fulvio A. Scorza

  • ·Response to Letter “Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out”

    Morgane Chamboux, Corinne Simon, Frédérique Beau-Salinas, Anaïs Maurier, Marie Sara Agier, Eve Marie Thillard, Bérenger Largeau, Annie-Pierre Jonville-Bera